Animal models for studying female genital tract infection with chlamydia trachomatis

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3060-3067

  De Clercq, Evelien ^a   Kalmar, Isabelle ^a   Vanrompay, Daisy ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; ESTRADIOL; GAMMA INTERFERON; INDOLE 2,3 DIDEOXYGENASE; INDOLE DERIVATIVE; PROGESTERONE; TRYPTOPHAN; TRYPTOPHAN SYNTHASE; UNCLASSIFIED DRUG; VACCINE;

ADAPTIVE IMMUNITY; ARTIFICIAL INSEMINATION; BIOTYPE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHLAMYDIASIS; CONJUNCTIVITIS; ENDOMETRITIS; FEMALE GENITAL TRACT INFECTION; GUINEA PIG MODEL; HISTOPATHOLOGY; LYMPH FOLLICLE; MACACA; NONHUMAN; PATHOGENESIS; PRIMATE MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALPINGITIS; SEXUAL TRANSMISSION; SHORT SURVEY;

EID: 84884262262     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00357-13     Document Type: Short Survey

References (112)

1. WHO. 2012. Global incidence and prevalence of selected curable sexually transmitted infections - 2008. World Health Organization, Geneva, Switzerland.
2. CDC. December 2012. Sexually transmitted disease surveillance 2011 Division of STD Prevention, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA.
3. van de Laar MJ, Morre SA. 2007. Chlamydia: a major challenge for public health. Euro Surveill. 12(10):E1-2. http://www.ncbi.nlm.nih.gov/pubmed?term=Chlamydia%3A+a+major+challenge+for+public+health&TransSchema=title&cmd=detailssearch.
4. Ibrahim AA, Refeidi A, El Mekki AA. 1996. Etiology and clinical features of acute epididymo-orchitis. Ann. Saudi Med. 16:171-174.
5. Taylor-Robinson D, Thomas BJ. 1980. The role of Chlamydia trachomatis in genital-tract and associated diseases. J. Clin. Pathol. 33:205-233.
6. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. 1992. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex. Transm. Dis. 19:185-192.
7. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. 2010. Risk of sequelae after Chlamydia trachomatis genital infection in women. J. Infect. Dis. 201(Suppl 2):S134-S155.
8. de la Maza MA, de la Maza LM. 1995. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 13:119-127.
9. Barron AL, White HJ, Rank RG, SoloffBL, Moses EB. 1981. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 143:63-66.
10. Tuffrey M, Taylor-Robinson D. 1981. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol. Lett. 12:111-115.
11. Mount DT, Bigazzi PE, Barron AL. 1972. Infection of genital tract and transmission of ocular infection to newborns by the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 5:921-926.
12. Mount DT, Bigazzi PE, Barron AL. 1973. Experimental genital infection of male guinea pigs with the agent of guinea pig inclusion conjunctivitis and transmission to females. Infect. Immun. 8:925-930.
13. Patton DL, Halbert SA, Kuo CC, Wang SP, Holmes KK. 1983. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys. Fertil. Steril. 40:829-840.
14. Patton DL, Kuo CC, Wang SP, Brenner RM, Sternfeld MD, Morse SA, Barnes RC. 1987. Chlamydial infection of subcutaneous fimbrial transplants in cynomolgus and rhesus monkeys. J. Infect. Dis. 155:229-235.
15. Vanrompay D, Hoang TQ, De Vos L, Verminnen K, Harkinezhad T, Chiers K, Morre SA, Cox E. 2005. Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection. Infect. Immun. 73:8317-8321.
16. Kaushic C, Murdin AD, Underdown BJ, Wira CR. 1998. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect. Immun. 66:893-898.
17. Patton DL, Halbert SA, Wang SP. 1982. Experimental salpingitis in rabbits provoked by Chlamydia trachomatis. Fertil. Steril. 37:691-700.
18. Vanrompay D, Lyons JM, Morre SA. 2006. Animal models for the study of Chlamydia trachomatis infections in the female genital infection. Drugs Today (Barc) 42(Suppl A):55-63.
19. Nigg C. 1942. An unidentified virus which produces pneumonia and systemic infection in mice. Science 95:49-50.
20. de la Maza LM, Pal S, Khamesipour A, Peterson EM. 1994. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect. Immun. 62:2094-2097.
21. Morrison RP, Caldwell HD. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-2751.
22. Shah AA, Schripsema JH, Imtiaz MT, Sigar IM, Kasimos J, Matos PG, Inouye S, Ramsey KH. 2005. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex. Transm. Dis. 32:49-56.
23. Pal S, Peterson EM, De La Maza LM. 1999. A murine model for the study of Chlamydia trachomatis genital infections during pregnancy. Infect. Immun. 67:2607-2610.
24. Morrison RP, Feilzer K, Tumas DB. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4661-4668.
25. Ramsey KH, Cotter TW, Salyer RD, Miranpuri GS, Yanez MA, Poulsen CE, DeWolfe JL, Byrne GI. 1999. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect. Immun. 67:3019-3025.
26. Morrison SG, Morrison RP. 2000. In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect. Immun. 68:2870-2879.
27. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. 1993. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg. Immunol.5:317-324.
28. Ramsey KH, Rank RG. 1991. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect. Immun. 59:925-931.
29. Rank RG, Ramsey KH, Pack EA, Williams DM. 1992. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect. Immun. 60:4427-4429.
30. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65:2145-2152.
31. Perry LL, Feilzer K, Caldwell HD. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J. Immunol. 158:3344-3352.
32. Morrison RP. 2000. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect. Immun. 68: 6038-6040.
33. + T cells in antichlamydial immunity defined by Chlamydiaspecific T-lymphocyte clones. Infect. Immun. 62:5195-5197.
34. + T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect. Immun. 79:2928-2935.
35. Ramsey KH, Soderberg LS, Rank RG. 1988. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect. Immun. 56:1320-1325.
36. Su H, Feilzer K, Caldwell HD, Morrison RP. 1997. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65:1993-1999.
37. + T cells. Infect. Immun. 68:6979-6987.
38. + T cells and antibody are required for optimal major outer membrane protein vaccineinduced immunity to Chlamydia muridarum genital infection. Infect. Immun. 78:4374-4383.
39. Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF. 2006. Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun. 7:122-129.
40. Darville T, Andrews CW, Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 65:3065-3073.
41. Maxion HK, Liu W, Chang MH, Kelly KA. 2004. The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection. Infect. Immun. 72:6330-6340.
42. Pal S, Peterson EM, de la Maza LM. 2001. Susceptibility of mice to vaginal infection with Chlamydia trachomatis mouse pneumonitis is dependent on the age of the animal. Infect. Immun. 69:5203-5206.
43. Pal S, Hui W, Peterson EM, de la Maza LM. 1998. Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection. J. Med. Microbiol. 47:599-605.
44. Swenson CE, Donegan E, Schachter J. 1983. Chlamydia trachomatisinduced salpingitis in mice. J. Infect. Dis. 148:1101-1107.
45. Farris CM, Morrison RP. 2011. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect. Immun. 79:986-996.
46. Ramsey KH, DeWolfe JL, Salyer RD. 2000. Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis. Infect. Immun. 68:7186-7189.
47. Ito JI, Jr, Lyons JM, Airo-Brown LP. 1990. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect. Immun. 58:2021-2023.
48. Carmichael JR, Tifrea D, Pal S, de la Maza LM. 2013. Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model. Microbes Infect. 15:219-229.
49. + T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract. J. Immunol. 189:2441-2449.
50. Tuffrey M, Alexander F, Inman C, Ward ME. 1990. Correlation of infertility with altered tubal morphology and function in mice with salpingitis induced by a human genital-tract isolate of Chlamydia trachomatis. J. Reprod. Fertil. 88:295-305.
51. Tuffrey M, Falder P, Gale J, Taylor-Robinson D. 1986. Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br. J. Exp. Pathol. 67:605-616.
52. Sturdevant GL, Kari L, Gardner DJ, Olivares-Zavaleta N, Randall LB, Whitmire WM, Carlson JH, Goheen MM, Selleck EM, Martens C, Caldwell HD. 2010. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect. Immun. 78:3660-3668.
53. Brunham RC, Rey-Ladino J. 2005. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5:149-161.
54. Brunham RC, Zhang DJ, Yang X, McClarty GM. 2000. The potential for vaccine development against chlamydial infection and disease. J. Infect. Dis. 181(Suppl 3):S538-S543.
55. Hafner L, Beagley K, Timms P. 2008. Chlamydia trachomatis infection: host immune responses and potential vaccines. Mucosal Immunol. 1:116-130.
56. Perry LL, Su H, Feilzer K, Messer R, Hughes S, Whitmire W, Caldwell HD. 1999. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J. Immunol. 162:3541-3548.
57. Tuffrey M, Falder P, Taylor-Robinson D. 1982. Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br. J. Exp. Pathol. 63:539-546.
58. + T cells and diminished adaptive immunity. J. Infect. Dis. 203:1120-1128.
59. Lyons JM, Morre SA, Airo-Brown LP, Pena AS, Ito JI. 2005. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice. J. Microbiol. Immunol. Infect. 38:383-393.
60. Kita E, Yagyu Y, Nishikawa F, Hamuro A, Oku D, Emoto M, Katsui N, Kashiba S. 1989. Alterations of host resistance to mouse typhoid infection by sex hormones. J. Leukoc. Biol. 46:538-546.
61. Belland RJ, Scidmore MA, Crane DD, Hogan DM, Whitmire W, McClarty G, Caldwell HD. 2001. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. U. S. A. 98:13984-13989.
62. Read TD, Brunham RC, Shen C, Gill SR, Heidelberg JF, White O, Hickey EK, Peterson J, Utterback T, Berry K, Bass S, Linher K, Weidman J, Khouri H, Craven B, Bowman C, Dodson R, Gwinn M, Nelson W, DeBoy R, Kolonay J, McClarty G, Salzberg SL, Eisen J, Fraser CM. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28:1397-1406.
63. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L, Mitchell W, Olinger L, Tatusov RL, Zhao Q, Koonin EV, Davis RW. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754-759.
64. Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, Whitmire WM, Crane DD, Steele-Mortimer O, Kari L, McClarty G, Caldwell HD. 2005. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc. Natl. Acad. Sci. U. S. A. 102:10658-10663.
65. Tietzel I, El-Haibi C, Carabeo RA. 2009. Human guanylate binding proteins potentiate the anti-Chlamydia effects of interferon-gamma. PLoS One 4:e6499. doi:10.1371/journal.pone.0006499.
66. Carlson JH, Hughes S, Hogan D, Cieplak G, Sturdevant DE, McClarty G, Caldwell HD, Belland RJ. 2004. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect. Immun. 72:7063-7072.
67. Lo CC, Xie G, Bonner CA, Jensen RA. 2012. The alternative translational profile that underlies the immune-evasive state of persistence in Chlamydiaceae exploits differential tryptophan contents of the protein repertoire. Microbiol. Mol. Biol. Rev. 76:405-443.
68. Johansson M, Schon K, Ward M, Lycke N. 1997. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65:1032-1044.
69. Morre SA, Lyons JM, Ito JI, Jr. 2000. Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains. Infect. Immun. 68:7209-7211.
70. Lyons JM, Ito JI, Jr, Pena AS, Morre SA. 2005. Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum. J. Clin. Pathol. 58:397-401.
71. Coers J, Gondek DC, Olive AJ, Rohlfing A, Taylor GA, Starnbach MN. 2011. Compensatory T cell responses in IRG-deficient mice prevent sustained Chlamydia trachomatis infections. PLoS Pathog. 7:e1001346. doi: 10.1371/journal.ppat.1001346.
72. Johnson AP, Hetherington CM, Osborn MF, Thomas BJ, Taylor-Robinson D. 1980. Experimental infection of the marmoset genital tract with Chlamydia trachomatis. Br. J. Exp. Pathol. 61:291-295.
73. Ripa KT, Moller BR, Mardh PA, Freundt EA, Melsen F. 1979. Experimental acute salpingitis in grivet monkeys provoked by Chlamydia trachomatis. Acta Pathol. Microbiol. Scand. B 87B:65-70.
74. Thygeson P, Mengert WF. 1936. The virus of inclusion conjunctivitis. Arch. Ophthalmol. 15:377-410.
75. Bell JD, Bergin IL, Schmidt K, Zochowski MK, AronoffDM, Patton DL. 2011. Nonhuman primate models used to study pelvic inflammatory disease caused by Chlamydia trachomatis. Infect. Dis. Obstet. Gynecol. 2011:675360. doi:10.1155/2011/675360.
76. Patton DL, Sweeney YC, Rabe LK, Hillier SL. 1996. The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem. Sex. Transm. Dis. 23:489-493.
77. Patton DL, Sweeney YT, Paul KJ. 2009. A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model. Sex. Transm. Dis. 36:350-356.
78. Miyairi I, Ramsey KH, Patton DL. 2010. Duration of untreated chlamydial genital infection and factors associated with clearance: review of animal studies. J. Infect. Dis. 201(Suppl 2):S96-S103.
79. Patton DL. 1985. Immunopathology and histopathology of experimental chlamydial salpingitis. Rev. Infect. Dis. 7:746-753.
80. Wolner-Hanssen P, Patton DL, Holmes KK. 1991. Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex. Transm. Dis. 18:21-25.
81. Patton DL, Wolner-Hanssen P, Cosgrove SJ, Holmes KK. 1990. The effects of Chlamydia trachomatis on the female reproductive tract of the Macaca nemestrina after a single tubal challenge following repeated cervical inoculations. Obstet. Gynecol. 76:643-650.
82. Patton DL, Kuo CC, Wang SP, Halbert SA. 1987. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J. Infect. Dis. 155:1292-1299.
83. Patton DL, Sweeney YC, Bohannon NJ, Clark AM, Hughes JP, Cappuccio A, Campbell LA, Stamm WE. 1997. Effects of doxycycline and antiinflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques. J. Infect. Dis. 175:648-654.
84. Patton DL, Sweeney YT, Stamm WE. 2005. Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment. J. Infect. Dis. 192:129-135.
85. Patton DL, Kuo CC, Brenner RM. 1989. Chlamydia trachomatis oculogenital infection in the subcutaneous autotransplant model of conjunctiva, salpinx and endometrium. Br. J. Exp. Pathol. 70:357-367.
86. Patton DL, Kuo CC. 1989. Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model. J. Reprod. Fertil. 85:647-656.
87. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. 1997. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect. Immun. 65:2175-2182.
88. Bell JD, Bergin IL, Schmidt K, Zochowski MK, AronoffDM, Patton DL. 2011. Nonhuman primate models used to study pelvic inflammatory disease caused by Chlamydia trachomatis. Infect. Dis. Obstet. Gynecol. 2011:675360. doi:10.1155/2011/675360.
89. Coers J, Starnbach MN, Howard JC. 2009. Modeling infectious disease in mice: co-adaptation and the role of host-specific IFNgamma responses. PLoS Pathog. 5:e1000333. doi:10.1371/journal.ppat.1000333.
90. Murray ES. 1964. Guinea pig inclusion conjunctivitis virus. I. Isolation and identification as a member of the psittacosis-lymphogranulomatrachoma group. J. Infect. Dis. 114:1-12.
91. Barron AL, White HJ, Rank RG, SoloffBL. 1979. Target tissues associated with genital infection of female guinea pigs by the chlamydial agent of guinea pig inclusion conjunctivitis. J. Infect. Dis. 139:60-68.
92. Rank RG, Sanders MM. 1992. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am. J. Pathol. 140:927-936.
93. Rank RG, Bowlin AK, Reed RL, Darville T. 2003. Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose. Infect. Immun. 71:6148-6154.
94. Alexander NJ (ed). 1979. Animal models for research on contraception and fertility. Harper&Row, Hagerstown, Md.
95. Sisk DB. 1976. Physiology, p 63-98. In Wagner JE, Manning PJ (ed), The biology of the guinea pig. Academic Press, Inc., New York, NY.
96. Pasley JN, Rank RG, Hough AJ, Jr, Cohen C, Barron AL. 1985. Absence of progesterone effects on chlamydial genital infection in female guinea pigs. Sex. Transm. Dis. 12:155-158.
97. Rank RG, White HJ, Hough AJ, Jr, Pasley JN, Barron AL. 1982. Effect of estradiol on chlamydial genital infection of female guinea pigs. Infect. Immun. 38:699-705.
98. Sweet RL, Blankfort-Doyle M, Robbie MO, Schacter J. 1986. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 255:2062-2064.
99. Agrawal T, Vats V, Wallace PK, Salhan S, Mittal A. 2008. Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection. Reprod. Biol. Endocrinol. 6:46. doi:10.1186/1477-7827-6-46.
100. Rank RG, White HJ, Barron AL. 1979. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 26:573-579.
101. Rank RG, Barron AL. 1983. Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect. Immun. 41:876-879.
102. Rank RG, Soderberg LS, Sanders MM, Batteiger BE. 1989. Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 57:706-710.
103. Rank RG, Batteiger BE, Soderberg LS. 1988. Susceptibility to reinfection after a primary chlamydial genital infection. Infect. Immun. 56:2243-2249.
104. Rank RG, Batteiger BE, Soderberg LS. 1990. Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes. Infect. Immun. 58: 2599-2605.
105. Batteiger BE, Rank RG, Bavoil PM, Soderberg LS. 1993. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J. Gen. Microbiol. 139:2965-2972.
106. Andrew DW, Hafner LM, Beagley KW, Timms P. 2011. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model. J. Reprod. Immunol. 91:9-16.
107. Bray N, Dubchak I, Pachter L. 2003. AVID: a global alignment program. Genome Res. 13:97-102.
108. Tuggle CK, Green JA, Fitzsimmons C, Woods R, Prather RS, Malchenko S, Soares BM, Kucaba T, Crouch K, Smith C, Tack D, Robinson N, O'Leary B, Scheetz T, Casavant T, Pomp D, Edeal BJ, Zhang Y, Rothschild MF, Garwood K, Beavis W. 2003. EST-based gene discovery in pig: virtual expression patterns and comparative mapping to human. Mamm. Genome 14:565-579.
109. Dawson H, Reece J, Urban J. 2007. A comparative analysis of the porcine, murine, and human immune systems, p 120. Abstr. Eighth Vet. Immunol. Int. Symp., Ouro Preto, Brazil.
110. Schautteet K, Stuyven E, Cox E, Vanrompay D. 2011. Validation of the Chlamydia trachomatis genital challenge pig model for testing recombinant protein vaccines. J. Med. Microbiol. 60:117-127.
111. Schautteet K, De Clercq E, Jonsson Y, Lagae S, Chiers K, Cox E, Vanrompay D. 2012. Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization. Vaccine 30:2869-2881.
112. Schautteet K, Stuyven E, Beeckman DS, Van Acker S, Carlon M, Chiers K, Cox E, Vanrompay D. 2011. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa. Vaccine 29:1399-1407.